Anja heads our Life Sciences & Healthcare group in Germany. She is a specialist lawyer for intellectual property law and has been working in the area of patent law for over 15 years. Anja manages and coordinates complex, multinational patent infringement proceedings and drafts infringement and nullity opinions.

 

She advises on parallel opposition and nullity proceedings before the European Patent Office, the Federal Patent Court and the Federal Supreme Court. In particular, Anja represents clients from the fields of pharmaceuticals, biotech, personalised medicine and precision medicine as well as from the chemical and medical device industries and advises on related issues of digitisation. Having spent time in Geneva, Strasbourg, Tokyo and London, Anja has intercultural competence and language skills (including English, French and Japanese).

显示完整简历 隐藏完整简历

Hot Topic: UPC

Read more

最新新闻和观点

UPC

What is new on preliminary injunction proceedings in pharma and biotech cases in Germany – and would it be different under the UPC?

2022年9月14日
Briefing

作者 Dr. Anja Lunze, LL.M.

点击此处了解更多
UPC

UPC opt-out: "Should I stay or should I go?"

2022年4月6日
Briefing

作者 Dr. Anja Lunze, LL.M. 以及 Alina Krukover

点击此处了解更多
UPC

Will the Unitary Patent be joined by a Unitary SPC right?

2022年3月17日
Quick read

作者

点击此处了解更多
UPC

The Unified Patent Court (“UPC”) and Unitary Patents

2021年12月17日
In-depth analysis

作者

点击此处了解更多

与我会面: